Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v11-FR | Version v10-EN | |
---|---|---|
Language | French | English |
Date Updated | 2020-01-16 | 2020-01-16 |
Drug Identification Number | 02439379 | 02439379 |
Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
Common or Proper name | Ropivacaine | Ropivacaine |
Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
Ingredients | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE |
Strength(s) | 2MG | 2MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | EPIDURAL INFILTRATION | EPIDURAL INFILTRATION |
Packaging size | 200mL Freeflex bag | 200mL Freeflex bag |
ATC code | N01BB | N01BB |
ATC description | ANESTHETICS, LOCAL | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | ||
Actual start date | 2019-07-26 | 2019-07-26 |
Estimated end date | 2019-10-31 | 2019-10-31 |
Actual end date | 2020-01-03 | 2020-01-03 |
Shortage status | Resolved | Resolved |
Tier 3 Status | No | No |
Company comments | Available from January 3, 2020 | Available from January 3, 2020 |
Health Canada comments |